SHASQI
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ (Click Activated Protodrugs Against Cancer) platform. The technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two ‘click’, a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds. We have already proven that our platform works in humans, which opens up an array of future possibilities for click-chemistry based therapies.
SHASQI
Industry:
Biotechnology Emergency Medicine Health Care Medical
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.shasqi.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
64.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Global Site Tag Microsoft Exchange Online
Similar Organizations
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Shasqi
William J. Rieflin
William J. Rieflin investment in Series B - Shasqi
Juan Jaen
Juan Jaen investment in Series B - Shasqi
National Cancer Institute
National Cancer Institute investment in Grant - Shasqi
Endpoint Ventures
Endpoint Ventures investment in Series A - Shasqi
Y Combinator
Y Combinator investment in Series A - Shasqi
Y Combinator
Y Combinator investment in Pre Seed Round - Shasqi
Newest Events participated
Participated in Y Combinator Winter 2015 Demo Day
on 2015-03-23 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.shasqi.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
